Cargando…

Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current

BACKGROUND: Innovative technical approaches to controlling undesired sensory and motor activity, such as hyperalgesia or spasticity, may contribute to rehabilitation techniques for improving neural plasticity in patients with neurologic disorders. To date, transcutaneous electrical stimulation has u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yushin, Cho, Hang-Jun, Park, Hyung-Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102860/
https://www.ncbi.nlm.nih.gov/pubmed/30126438
http://dx.doi.org/10.1186/s12984-018-0421-8
_version_ 1783349254503268352
author Kim, Yushin
Cho, Hang-Jun
Park, Hyung-Soon
author_facet Kim, Yushin
Cho, Hang-Jun
Park, Hyung-Soon
author_sort Kim, Yushin
collection PubMed
description BACKGROUND: Innovative technical approaches to controlling undesired sensory and motor activity, such as hyperalgesia or spasticity, may contribute to rehabilitation techniques for improving neural plasticity in patients with neurologic disorders. To date, transcutaneous electrical stimulation has used low frequency pulsed currents for sensory inhibition and muscle activation. Yet, few studies have attempted to achieve motor nerve inhibition using transcutaneous electrical stimulation. This study aimed to develop a technique for transcutaneous electrical nerve inhibition (TENI) using medium-frequency alternating current (MFAC) to suppress both sensory and motor nerve activity in humans. METHODS: Surface electrodes were affixed to the skin of eight young adults to stimulate the median nerve. Stimulation intensity was increased up to 50% and 100% of the pain threshold. To identify changes in sensory perception by transcutaneous MFAC (tMFAC) stimulation, we examined tactile and pressure pain thresholds in the index and middle fingers before and after stimulation at 10 kHz. To demonstrate the effect of tMFAC stimulation on motor inhibition, stimulation was applied while participants produced flexion forces with the index and middle fingers at target forces (50% and 90% of MVC, maximum voluntary contraction). RESULTS: tMFAC stimulation intensity significantly increased tactile and pressure pain thresholds, indicating decreased sensory perception. During the force production task, tMFAC stimulation with the maximum intensity immediately reduced finger forces by ~ 40%. Finger forces recovered immediately after stimulation cessation. The effect on motor inhibition was greater with the higher target force (90% MVC) than with the lower target (50% MVC). Also, higher tMFAC stimulation intensity provided a greater inhibition effect on both sensory and motor nerve activity. CONCLUSION: We found that tMFAC stimulation immediately inhibits sensory and motor activity. This pre-clinical study demonstrates a novel technique for TENI using MFAC stimulation and showed that it can effectively inhibit both sensory perception and motor activity. The proposed technique can be combined with existing rehabilitation devices (e.g., a robotic exoskeleton) to inhibit undesired sensorimotor activities and to accelerate recovery after neurologic injury.
format Online
Article
Text
id pubmed-6102860
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61028602018-08-27 Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current Kim, Yushin Cho, Hang-Jun Park, Hyung-Soon J Neuroeng Rehabil Research BACKGROUND: Innovative technical approaches to controlling undesired sensory and motor activity, such as hyperalgesia or spasticity, may contribute to rehabilitation techniques for improving neural plasticity in patients with neurologic disorders. To date, transcutaneous electrical stimulation has used low frequency pulsed currents for sensory inhibition and muscle activation. Yet, few studies have attempted to achieve motor nerve inhibition using transcutaneous electrical stimulation. This study aimed to develop a technique for transcutaneous electrical nerve inhibition (TENI) using medium-frequency alternating current (MFAC) to suppress both sensory and motor nerve activity in humans. METHODS: Surface electrodes were affixed to the skin of eight young adults to stimulate the median nerve. Stimulation intensity was increased up to 50% and 100% of the pain threshold. To identify changes in sensory perception by transcutaneous MFAC (tMFAC) stimulation, we examined tactile and pressure pain thresholds in the index and middle fingers before and after stimulation at 10 kHz. To demonstrate the effect of tMFAC stimulation on motor inhibition, stimulation was applied while participants produced flexion forces with the index and middle fingers at target forces (50% and 90% of MVC, maximum voluntary contraction). RESULTS: tMFAC stimulation intensity significantly increased tactile and pressure pain thresholds, indicating decreased sensory perception. During the force production task, tMFAC stimulation with the maximum intensity immediately reduced finger forces by ~ 40%. Finger forces recovered immediately after stimulation cessation. The effect on motor inhibition was greater with the higher target force (90% MVC) than with the lower target (50% MVC). Also, higher tMFAC stimulation intensity provided a greater inhibition effect on both sensory and motor nerve activity. CONCLUSION: We found that tMFAC stimulation immediately inhibits sensory and motor activity. This pre-clinical study demonstrates a novel technique for TENI using MFAC stimulation and showed that it can effectively inhibit both sensory perception and motor activity. The proposed technique can be combined with existing rehabilitation devices (e.g., a robotic exoskeleton) to inhibit undesired sensorimotor activities and to accelerate recovery after neurologic injury. BioMed Central 2018-08-20 /pmc/articles/PMC6102860/ /pubmed/30126438 http://dx.doi.org/10.1186/s12984-018-0421-8 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kim, Yushin
Cho, Hang-Jun
Park, Hyung-Soon
Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current
title Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current
title_full Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current
title_fullStr Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current
title_full_unstemmed Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current
title_short Technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current
title_sort technical development of transcutaneous electrical nerve inhibition using medium-frequency alternating current
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6102860/
https://www.ncbi.nlm.nih.gov/pubmed/30126438
http://dx.doi.org/10.1186/s12984-018-0421-8
work_keys_str_mv AT kimyushin technicaldevelopmentoftranscutaneouselectricalnerveinhibitionusingmediumfrequencyalternatingcurrent
AT chohangjun technicaldevelopmentoftranscutaneouselectricalnerveinhibitionusingmediumfrequencyalternatingcurrent
AT parkhyungsoon technicaldevelopmentoftranscutaneouselectricalnerveinhibitionusingmediumfrequencyalternatingcurrent